Breaking News Instant updates and real-time market news.

EPC

Edgewell Personal Care

$78.93

1.13 (1.45%)

, KHC

Kraft Heinz

$87.28

-3.815 (-4.19%)

10:27
02/17/17
02/17
10:27
02/17/17
10:27

Edgewell Personal Care remains takeout target, says RBC Capital

After Kraft Heinz (KHC) confirmed it had approached Unilever (UN, UL) with a merger proposal, RBC Capital analyst Nik Modi says the news come as a surprise, but does not warrant a change in his Edgewell Personal Care (EPC) takeout thesis. The analyst reiterates an Outperform rating on the latter's shares, with a $105 price target, on improving margin and revenue profile and the prospects of a takeout in the next 12-16 months, with Unilever as one of the more likely buyers. Other potential suitors include Kimberly-Clark (KMB), Beiersdorf, Henkel, Johnson & Johnson (JNJ), Colgate-Palmolive (CL), Church & Dwight (CHD), L'Oreal (LRLCY), and Kao, he adds.

EPC

Edgewell Personal Care

$78.93

1.13 (1.45%)

KHC

Kraft Heinz

$87.28

-3.815 (-4.19%)

UN

Unilever; also tag UL

$46.69

4.37 (10.33%)

UL

Unilever; also tag UN

$46.42

3.85 (9.04%)

KMB

Kimberly-Clark

$130.41

3.79 (2.99%)

JNJ

Johnson & Johnson

$118.44

0.36 (0.30%)

CL

Colgate-Palmolive

$72.34

3.34 (4.84%)

CHD

Church & Dwight

$49.70

0.77 (1.57%)

LRLCY

L'Oreal

$36.72

-0.115 (-0.31%)

  • 20

    Feb

  • 22

    Feb

  • 24

    Feb

  • 09

    Mar

  • 19

    Mar

  • 27

    Mar

EPC Edgewell Personal Care
$78.93

1.13 (1.45%)

05/03/16
JEFF
05/03/16
DOWNGRADE
Target $87
JEFF
Hold
Edgewell Personal Care downgraded to Hold from Buy at Jefferies
Jefferies analyst Kevin Grundy downgraded Edgewell Personal Care to Hold citing the recent rally in the shares and lower conviction in his takeover thesis following the change in the Chairman position. The analyst believes a buyout in the near-term is now less likely and cut his price target for the name to $87 from $95.
08/26/16
JEFF
08/26/16
NO CHANGE
Target $75
JEFF
Hold
Jefferies cuts Edgewell Personal Care target citing Harry's rollout at Target
Jefferies analyst Kevin Grundy lowered his price target on Edgewell Personal Care (EPC) to $75 from $77 after Harry's shave club offerings launched nationwide at Target (TGT), saying his store checks revealed strong in-store execution for the roll-out. Grundy thinks soon-to-be acquired Dollar Shave Club will also to push into retail and expects other retailers, perhaps including Walmart (WMT), to follow Target's lead and offer shelf space to the "trendy" shave club brands. While saying this is also a risk to Procter & Gamble (PG), Grundy keeps his Buy rating and $98 price target on P&G shares, saying increased levels of investment in U.S. shaving are already factored in the company's guidance.
09/12/16
BOFA
09/12/16
DOWNGRADE
Target $84
BOFA
Neutral
Edgewell Personal Care downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Edgewell Personal Care to Neutral and lowered its price target to $84 citing sluggish underlying trends and balanced risk/reward.
KHC Kraft Heinz
$87.28

-3.815 (-4.19%)

02/16/17
SUSQ
02/16/17
DOWNGRADE
SUSQ
Neutral
Kraft Heinz downgraded to Neutral from Positive at Susquehanna
02/13/17
UBSW
02/13/17
NO CHANGE
Target $98
UBSW
Buy
UBS offers three reasons to own Kraft Heinz
UBS analyst Steven Strycula gave three reasons town Kraft Heinz shares. He noted its outsized earnings growth versus peers, the potential to increase its cost savings target, and its ability to increase pricing trends through the rollout of revenue management across its legacy revenue portfolio. Strycula reiterated his Buy rating and $98 price target on Kraft Heinz shares.
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
02/15/17
DBAB
02/15/17
INITIATION
Target $103
DBAB
Buy
Kraft Heinz initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Rob Dickerson started Kraft Heinz with a Buy rating and $103 price target.
UN Unilever; also tag UL
$46.69

4.37 (10.33%)

01/23/17
01/23/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Market Perform from Outperform at Wells Fargo with analyst Jennifer Fritzsche saying the stock's outperformance since U.S. presidential election is not sustainable given growth headwinds in 2017. 2. Qualcomm (QCOM) downgraded to Neutral from Buy at Nomura and to Underperform from Buy at CLSA. 3. Schlumberger (SLB) downgraded to Equal Weight from Overweight at Stephens with analyst Matthew Marietta saying he remains confident in Schlumberger's ability to benefit from the Cameron (CAM) integration, and its wide-ranging suite of products/services. 4. Unilever (UL, UN) downgraded to Equal Weight from Overweight at Barclays with analyst Simon Hales citing recent sector outperformance, currency uncertainty, and rising oil related input costs. 5. Kansas City Southern (KSU) downgraded to Neutral from Accumulate at Seaport Global with analyst Mark Levin saying there is too much uncertainty around U.S./Mexico trade policy to accurately forecast what earnings will look like in 2019 and beyond. The analyst acknowledges shares are "cheap" and maintained his $90 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/23/17
LEHM
01/23/17
DOWNGRADE
LEHM
Equal Weight
Unilever downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Simon Hales downgraded Unilever to Equal Weight citing recent sector outperformance, currency uncertainty, and rising oil related input costs.
12/13/16
JEFF
12/13/16
UPGRADE
JEFF
Buy
Unilever upgraded to Buy from Hold at Jefferies
Jefferies analyst Martin Deboo upgraded Unilever to Buy and raised his price target for the shares to EUR 44 from EUR 40.
12/06/16
JPMS
12/06/16
DOWNGRADE
JPMS
Neutral
Unilever downgraded to Neutral from Overweight at JPMorgan
UL Unilever; also tag UN
$46.42

3.85 (9.04%)

KMB Kimberly-Clark
$130.41

3.79 (2.99%)

11/14/16
WELS
11/14/16
INITIATION
WELS
Market Perform
Kimberly-Clark coverage resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog resumed coverage on Kimberly-Clark with a Market Perform and a $117-$119 valuation range.
10/26/16
10/26/16
DOWNGRADE

Underperform
Kimberly-Clark downgraded to Underperform on emerging market weakness at CLSA
As previously reported, CLSA downgraded Kimberly-Clark to Underperform from Outperform and lowered its price target to $116 from $131. Analyst Caroline Levy believes pricing weakness in China will continue as P&G, Kao, and Unicharm, and local competitors compete for share. In the US, she expects P&G to remain aggressive in adult diaper promotions, a key category for Kimberly and said Brazil and Argentina have just begun to weaken. Levy's 2017 and 2018 estimates are below the Street and said a slight contraction in multiple is likely.
10/26/16
LYON
10/26/16
DOWNGRADE
LYON
Underperform
Kimberly-Clark downgraded to Underperform from Outperform at CLSA
01/09/17
LEHM
01/09/17
DOWNGRADE
Target $109
LEHM
Equal Weight
Kimberly-Clark downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Lauren Lieberman downgraded Kimberly-Clark to Equal Weight after lowering her U.S. Non-Food Consumer Staples sector view to Neutral from Positive. The analyst lowered her price target for the shares to $109 from $125. The analyst sees a less favorable macroeconomic backdrop in 2017 and has "fairly muted expectations" for company fundamentals in the space.
JNJ Johnson & Johnson
$118.44

0.36 (0.30%)

01/31/17
01/31/17
NO CHANGE

Deutsche sees label warnings as worst case for Actelion drug
After France's National Agency for the Safety of Medicines and Health Products, in a letter dated January 24, asked doctors to stop treating new patients with Actelion's (ALIOF) Uptravi as it investigates patient deaths, Deutsche Bank said it believes a label warnings for the pulmonary arterial hypertension drug is likely the worst case scenario. The firm thinks Johnson & Johnson (JNJ) likely knew of the letter before reaching an agreement to acquire Actelion. Shares of Actelion are down 4% to $65.40 in morning trading.
01/26/17
01/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) downgraded to Market Perform from Outperform at Wells Fargo with analyst Larry Biegelsen saying the company's "disappointing" 2017 revenue guidance suggests its pharma business is facing more headwinds than he expected. J&J guided to underlying sales growth in 2017 of 3.0%-3.5%, which is a "sharp deceleration" from 7.4% underlying growth in 2016, Biegelsen tells investors in a research note. Biegelsen downgraded Johnson & Johnson before the company's announced acquisition of Actelion (ALIOF). He wrote, though, that any deal wouldn't likely close until late 2017. 2. United Technologies (UTX) downgraded to Hold from Buy at Argus with analyst John Eade citing valuation. 3. Ethan Allen (ETH) downgraded to Neutral from Buy at Dougherty with analyst Jeremy Hamblin changing his views given a lack of visibility on the timing and impact on sales catalysts, including Disney Collection launch and US State Department contract, fewer new product introductions, tough second half of 2017 comps, and significant downside risk to consensus fiscal 2017 and fiscal 2018 estimates. 4. Hasbro (HAS) downgraded to Neutral from Buy at Monness Crespi. 5. Mattel (MAT) downgraded to Neutral from Buy at MKM Partners with analyst Eric Handler saying the turnaround story has lost momentum as a slower than expected retail environment, fewer product reorders, and increased promotional activity resulted in disappointing year-end results. Handler expects foreign exchange headwinds, rising input costs, and an unfavorable product mix to continue into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/02/17
JEFF
02/02/17
NO CHANGE
Target $53
JEFF
Buy
Jefferies sees J&J deal as not prohibiting Pacira takeover
Jefferies analyst David Steinberg says that after meeting with management, he has greater confidence that Pacira Pharmaceuticals' (PCRX) collaboration with Johnson & Johnson (JNJ) offers an opportunity for the company to meaningfully broaden the promotion of Exparel in surgical suites and potentially reaccelerate revenue starting in the second half of 2017. The analyst adds that his sense is the J&J partnership would not stand in the way of any potential takeover. Management did not disclose any stand-still or change of control provisions in its arrangement with J&J, Steinberg tells investors in a research note. The analyst keeps a Buy rating on Pacira with a $53 price target.
02/16/17
OPCO
02/16/17
NO CHANGE
OPCO
Outperform
Codman acquisition strengths Integra neurosurgery position, says Oppenheimer
Following the announcement that Integra LifeSciences (IART) acquired the Codman Neurosurgery Business from Johnson & Johnson (JNJ), Oppenheimer analyst Steven Lichtman says the addition brings complementary products to further strengthen the former's position in the neurosurgery market. Additionally, the analyst notes that the deal also expands Integra LifeSciences' international revenue and adds to the company's international infrastructure that will be supportive primarily of its neurosurgery business, but will also help in the international build-out of other segments. He reiterates an Outperform rating on Integra LifeSciences' shares.
CL Colgate-Palmolive
$72.34

3.34 (4.84%)

01/25/17
BREN
01/25/17
INITIATION
Target $68
BREN
Hold
Colgate-Palmolive initiated with a Hold at Berenberg
Berenberg analyst Rosie Edwards initiated Colgate-Palmolive with a Hold and a $68 price target citing slowing market shares gains and organic growth.
01/30/17
01/30/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Colgate-Palmolive (CL) downgraded to Neutral from Buy at Citi with analyst Wendy Nicholson saying the sales the "breadth of the top-line weakness" in the company's fourth quarter results is "very disconcerting." Even with the 5% post-earnings pullback, Colgate shares are still not cheap, Nicholson tells investors in a research note. She lowered her price target for the shares to $70 from $76. 2. Air Products (APD) downgraded to Neutral from Outperform at Baird with analyst David Manthey saying he believes the catalyst that led to identifiable margin improvement last quarter may have substantially played out and the company is now more exposed to sluggish economic trends that have underpinned his cautious thinking on Praxair (PX). Manthey lowered his price target to $140 from $146 on Air Products shares. 3. Barclays (BCS) downgraded to Sell from Hold at Berenberg with analyst Peter Richardson citing valuation and high investment banking expectations reflected in shares. 4. Symantec (SYMC) reinstated with a Neutral from Buy at Citi with analyst Walter Pritchard downgrading Symantec (SYMC) to Neutral from Buy after reinstating coverage of the name. The analyst sees "weaker strategic merit" in the company's LifeLock (LOCK) acquisition relative to the Blue Coat deal. He also believes success is being priced in with investors looking for $2.00-plus in earnings power. Pritchard raised his price target for Symantec shares to $29 from $26.50. 5. CONSOL (CNX) downgraded to Hold from Buy at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
SBSH
01/30/17
DOWNGRADE
Target $70
SBSH
Neutral
Colgate-Palmolive downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Colgate-Palmolive to Neutral saying the sales the "breadth of the top-line weakness" in the company's Q4 results is "very disconcerting." Even with the 5% post-earnings pullback, Colgate shares are still not cheap, Nicholson tells investors in a research note. She lowered her price target for the shares to $70 from $76.
01/25/17
01/25/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wal-Mart (WMT) resumed with a Market Perform at Wells Fargo. 2. Colgate-Palmolive (CL) initiated with a Hold at Berenberg. 3. Sysco (SYY) initiated with a Sector Perform at RBC Capital. 4. Carter's (CRI) initiated with an Overweight at Morgan Stanley. 5. American Eagle (AEO) initiated with a Neutral at Buckingham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CHD Church & Dwight
$49.70

0.77 (1.57%)

11/14/16
WELS
11/14/16
INITIATION
WELS
Market Perform
Church & Dwight coverage resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog resumed coverage on Church & Dwight with a Market Perform and a $44-$46 valuation range.
10/10/16
ATLE
10/10/16
INITIATION
Target $51
ATLE
Neutral
Church & Dwight initiated with a Neutral at Atlantic Equities
Atlantic Equities analyst Charles Eden initiated Church & Dwight with a Neutral rating and a $51 price target.
01/18/17
DBAB
01/18/17
DOWNGRADE
Target $48
DBAB
Hold
Church & Dwight downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Bill Schmitz downgraded Church & Dwight to Hold and raised its price target to $48 from $46. The analyst lowered his view saying valuation is full, organic growth is decelerating, and costs are rising.
12/16/16
BMOC
12/16/16
INITIATION
BMOC
Market Perform
Church & Dwight initiated with a Market Perform at BMO Capital
Analyst Shannon Coyne started Church & Dwight with a Market Perform rating and a $47 price target.
LRLCY L'Oreal
$36.72

-0.115 (-0.31%)

11/29/16
RBCM
11/29/16
UPGRADE
RBCM
Sector Perform
L'Oreal upgraded on make-up performance, share buyback potential at RBC Capital
As noted earlier, RBC Capital upgraded L'Oreal (LRLCY) to Sector Perform from Underperform. Analyst James Edwards upgraded the stock partly due to what he calls "the outstanding performance" of the company's make-up business. Additionally, he believes that the company could launch a significant share buyback initiative if Nestle (NSRGY) new CEO chooses to sell that company's 23% stake in L'Oreal. Edwards says that such a scenario is "a very real prospect." Target to $159 from $150.
11/29/16
RBCM
11/29/16
UPGRADE
RBCM
Sector Perform
L'Oreal upgraded to Sector Perform from Underperform at RBC Capital
RBC Capital analyst James Edwardes Jones upgraded L'Oreal to Sector Perform with a price target of EUR 159.
11/04/16
STFL
11/04/16
UPGRADE
STFL
Buy
L'Oreal upgraded to Buy from Hold at Stifel
Stifel analyst Mark Astrachan upgraded L'Oreal based on the acceleration of the company's sales growth in Q3. The analyst thinks that the acceleration indicates that the company is "gaining meaningful share" of the global beauty market, and he predicts that its sales will increase at least 4%-5% over the next two to three years.
01/11/17
UBSW
01/11/17
UPGRADE
UBSW
Buy
L'Oreal upgraded to Buy from Neutral at UBS

TODAY'S FREE FLY STORIES

CACC

Credit Acceptance

$326.25

3.97 (1.23%)

11:34
12/13/17
12/13
11:34
12/13/17
11:34
Hot Stocks
PlainSite says Credit Acceptance disclosures belie 'deeply flawed' model »

In a "Reality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSGP

CoStar Group

$287.83

-2.67 (-0.92%)

11:33
12/13/17
12/13
11:33
12/13/17
11:33
Conference/Events
CoStar Group management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

  • 26

    Feb

ROG

Rogers Corporation

$158.59

1.4 (0.89%)

11:30
12/13/17
12/13
11:30
12/13/17
11:30
Conference/Events
Rogers Corporation management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Dec

11:30
12/13/17
12/13
11:30
12/13/17
11:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

ROG

Rogers Corporation

$158.89

1.7 (1.08%)

11:29
12/13/17
12/13
11:29
12/13/17
11:29
Conference/Events
Rogers Corporation management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Dec

HDP

Hortonworks

$19.76

0.18 (0.92%)

11:25
12/13/17
12/13
11:25
12/13/17
11:25
Conference/Events
Hortonworks management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 26

    Feb

CACC

Credit Acceptance

$326.25

3.97 (1.23%)

11:20
12/13/17
12/13
11:20
12/13/17
11:20
Hot Stocks
Credit Acceptance moves lower following short report from PlainSite »

Shares of Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
12/13/17
12/13
11:17
12/13/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
12/13/17
12/13
11:16
12/13/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RL

Ralph Lauren

$96.15

-3.99 (-3.98%)

11:13
12/13/17
12/13
11:13
12/13/17
11:13
Hot Stocks
Ralph Lauren falls after Bofa/Merrill downgrade cites 'dimming' margin story »

Shares of Ralph Lauren…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.58

0.555 (0.91%)

11:10
12/13/17
12/13
11:10
12/13/17
11:10
Hot Stocks
Target: Shipt to continue to run business independently post-acquisition »

Shipt will be a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$63.48

0.41 (0.65%)

, T

AT&T

$37.75

-0.35 (-0.92%)

11:10
12/13/17
12/13
11:10
12/13/17
11:10
Hot Stocks
Cable, telecom stocks dip as T-Mobile plans to bring 'un-carrier' to TV »

T-Mobile (TMUS) is…

TMUS

T-Mobile

$63.48

0.41 (0.65%)

T

AT&T

$37.75

-0.35 (-0.92%)

ROKU

Roku

$46.95

-1.03 (-2.15%)

CMCSA

Comcast

$39.51

1.07 (2.78%)

CMCSK

Comcast

CHTR

Charter

$329.99

-1.5 (-0.45%)

VZ

Verizon

$52.82

-0.375 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

LITE

Lumentum

$51.75

-1.75 (-3.27%)

, FNSR

Finisar

$19.30

-0.51 (-2.57%)

11:09
12/13/17
12/13
11:09
12/13/17
11:09
Recommendations
Lumentum, Finisar, Apple analyst commentary  »

Apple's investment…

LITE

Lumentum

$51.75

-1.75 (-3.27%)

FNSR

Finisar

$19.30

-0.51 (-2.57%)

AAPL

Apple

$171.70

-0.97 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$185.73

-0.49 (-0.26%)

11:09
12/13/17
12/13
11:09
12/13/17
11:09
Periodicals
Netflix executive fired over Masterson assault comments, Page Six says »

Netflix director of kids…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.64

0.62 (1.02%)

11:06
12/13/17
12/13
11:06
12/13/17
11:06
Technical Analysis
Technical View: Target spikes after acquiring Shipt for $550M »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.70

0.68 (1.11%)

11:02
12/13/17
12/13
11:02
12/13/17
11:02
Hot Stocks
Breaking Hot Stocks news story on Target »

Target to bring same-day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.69

0.67 (1.10%)

11:01
12/13/17
12/13
11:01
12/13/17
11:01
Hot Stocks
Breaking Hot Stocks news story on Target »

Target: Same-day delivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$61.72

0.71 (1.16%)

11:01
12/13/17
12/13
11:01
12/13/17
11:01
Hot Stocks
Target to buy same-day delivery platform Shipt for $550M in cash »

Target announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AYI

Acuity Brands

$165.44

-8.79 (-5.05%)

10:59
12/13/17
12/13
10:59
12/13/17
10:59
Technical Analysis
Technical View: Acuity Brands tumbles, levels to watch »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 09

    Jan

10:52
12/13/17
12/13
10:52
12/13/17
10:52
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

VIPS

Vipshop

$8.30

0.115 (1.41%)

10:50
12/13/17
12/13
10:50
12/13/17
10:50
Options
Opening action in Vipshop far upside calls »

Opening action in Vipshop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$84.72

0.2568 (0.30%)

10:45
12/13/17
12/13
10:45
12/13/17
10:45
Periodicals
Novartis' Sandoz generics unit may sell or close some products, Reuters reports »

Novartis is in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 17

    May

TRN

Trinity Industries

$37.45

0.57 (1.55%)

10:45
12/13/17
12/13
10:45
12/13/17
10:45
Options
Trinity Industries call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALL

Allstate

$103.58

0.0401 (0.04%)

10:42
12/13/17
12/13
10:42
12/13/17
10:42
Hot Stocks
NY DFS announces agreements with Allstate, Liberty Mutual on auto insurance »

New York's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
12/13/17
12/13
10:40
12/13/17
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.